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ABSTRACT Anti-peptide antibodies that distinguish be-
tween the rat brain sodium channel subtypes referred to as RI
and RI, were prepared and used to determine their relative
expression in nerve and muscle tissues. Sodium channels
purified from rat brain are approximately 18% RI and 80%
RI,. In brain, the RI, subtype is preferentially expressed with
RI/RI, ratios ranging from 0.07 in the hippocampus to 0.17 in
the cerebral cortex. The RI subtype is preferentially expressed
in more caudal areas of the central nervous system with values
of RI/RI, of 0.98 for medulla oblongata and 2.2 for spinal cord.
Expression of additional unidentified sodium channel sub-
type(s) is detected in midbrain, medulla, and spinal cord, and
expression of unidentified sodium channel subtypes predomi-
nates over expression of RI and RI, in retina and optic nerve.
The RI and RI, subtypes are primarily expressed in the central
nervous system and are not detected in significant numbers in
skeletal or cardiac muscle, sympathetic ganglia, adrenal me-
dulla, sciatic nerve, or cauda equina. The RI, subtype appears
first in development of both brain and spinal cord but declines
in adult spinal cord as the RI subtype increases. The strict
regional expression of these two sodium channel subtypes
suggests that they may have distinct functional properties or
physiological roles.
Sodium channels isolated in functional form from rat brain,
rat and rabbit skeletal muscle, and electric eel electroplax all
contain a large glycoprotein subunit of 260 kDa as their
principal component (reviewed in refs. 1-4). In brain and
skeletal muscle, this a subunit is associated with one or two
smaller
.
subunits (3, 4). cDNA clones encoding the primary
structure of the a subunits from electroplax (5) and rat brain
(6-9) have been isolated, and the complete primary struc-
tures of a subunits from electroplax and rat brain have been
determined (5, 8). High molecular weight mRNA from rat
brain (10), a-subunit mRNA isolated by hybrid selection (9),
and a-subunit mRNA synthesized from cloned cDNA (11) all
direct the synthesis offunctional sodium channels in Xenopus
oocytes, indicating that the a-subunit mRNA contains all the
information necessary to specify a functional sodium channel
in this expression system.
Two recent lines of investigation indicate that there are
multiple subtypes of sodium channels expressed in mamma-
lian neurons. Polyclonal antibodies directed against the a
subunit of the rat brain sodium channel do not recognize
sodium channels in peripheral neurons (12). Moreover,
cDNA clones encoding three different a-subunit mRNAs
have been detected in rat brain, and two of these have been
fully sequenced (8). These two mRNAs encode a-subunit
subtypes called RI and RII (8), which have 87% identity in
their predicted amino acid sequences. In these studies, we
have analyzed the tissue-specific expression of the RI and RII
sodium channel subtypes using sequence-directed antibodies
that distinguish these two forms.
EXPERIMENTAL PROCEDURES
Materials. The catalytic subunit of cAMP-dependent pro-
tein kinase (13), saxitoxin (14, 15), purified sodium channels
(16), and 32P-labeled sodium channels (17) were prepared as
described.
Synthetic Peptides. Peptides SP1 (Cys-Ala-Tyr-Glu-Glu-
Gln-Asn-Gln-Ala-Thr-Leu-Glu-Glu-Ala-Glu-Asn-Lys-Glu-
Ala), corresponding to residues 425-442 of RI (8) or residues
427-444 of RI, (8) plus an N-terminal cysteine extension,
SP11 (Lys-Thr-Ala-Ser-Glu-His-Ser-Arg-Glu-Pro-Ser-Ala-
Ala-Gly-Arg-Leu-Ser-Asp), corresponding to residues 465-
481 of RI (8) plus an N-terminal lysine extension, and SP1111
(Lys-Ala-Ser-Ala-Glu-Ser-Arg-Asp-Phe-Ser-Gly-Ala-Gly-
Gly-Ile-Gly-Val-Phe-Ser-Glu), corresponding to residues
465-484 (8) plus an N-terminal lysine extension were syn-
thesized by the solid-phase method (18) and purified by
reversed-phase HPLC on a Vydac 218TP10 (10-gtm particle
size) column. The identity of the purified peptides was
verified by amino acid analysis and determination of the
amino acid sequence. SP1 was radiolabeled with 1251I by the
chloramine T method (19); SP11I and SP111, were radiola-
beled by reaction with the Bolton-Hunter reagent (20).
Preparation of Antibodies. The purified peptides were
coupled through amino groups to bovine serum albumin with
glutaraldehyde (21), dialyzed against phosphate-buffered sa-
line, emulsified in an equal volume of Freund's complete
(initial injection) or incomplete adjuvant, and injected in
multiple subcutaneous sites on New Zealand White rabbits at
3-week intervals. Antisera were collected after the second
injection and tested by radioimmunoassay (17). Antibodies
were purified by antigen affinity chromatography (12, 22).
Preparation of Tissue Fractions. A crude synaptosomal
membrane fraction (P3) was prepared from whole rat brain as
described (23). Electric eel brain and regions of rat brain were
homogenized in sucrose buffer (3.3 ml per gram of tissue)
consisting of 5 mM EDTA, 5 mM EGTA, 300 mM sucrose
(pH 7.4), phenylmethylsulfonyl fluoride (50 ,ug/ml), 1 ,uM
pepstatin A, and 1 mM iodoacetamide. Debris was removed
by centrifugation at 800 x g for 10 min, and the membranes
were collected by centrifugation at 100,000 x g for 60 min.
Brains from monkey, chicken, gecko, and frog were homog-
enized in 320 mM sucrose/5 mM potassium phosphate, pH
7.4/1.5 ,M phenylmethylsulfonyl fluoride/1 ,uM pepstatin
A/1 mM iodoacetamide. Freshly dissected retinae and optic
nerves were homogenized in 130 mM choline chloride/5.4
mM KCI/0.8 mM MgCl2/5.5 mM glucose/50 mM Hepes
(adjusted to pH 7.4 with Tris)/50 pug of phenylmethylsulfonyl
fluoride per mil/1 AM pepstatin A/1 mM iodoacetamide.
Frozen superior cervical ganglia, adrenal medullae, and
sciatic nerves (Rockland Scientific) were rapidly thawed and
homogenized in the sucrose homogenization buffer. Rat
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skeletal muscle was dissected from the hind legs, and a light
surface membrane fraction was prepared by a modification of
the method of Barchi et al. (24). Sodium channel concentra-
tion was determined by measurement of specific binding of
saxitoxin in membrane fractions at 00C using a rapid filtration
assay on GF/F filters (Whatman) at 20 nM saxitoxin (23).
Solubilization, Immunoprecipitation, and Phosphorylation
of Sodium Channels. Membrane fractions were diluted to 1
nM sodium channels (100 fmol per sample) as assessed by
saxitoxin binding activity in 100mM choline chloride/10 mM
EDTA/10 mM EGTA/50 mM potassium phosphate, pH
7.4/3-5% Triton X-100 containing the protease inhibitors
phenylmethylsulfonyl fluoride (50,4g/ml), iodoacetamide (1
mM), and pepstatin A (1 mM). After mixing for 30 min at 40C,
the residual membranes were sedimented at 8000 x g for 15
min. The supernatants were incubated for 16 hr with affinity-
purified antibodies at 4°C. The antigen-antibody complexes
were isolated by adsorption to protein A-Sepharose (10 mg),
and the pellets were washed twice with phosphorylation
buffer (25). The immunoprecipitated sodium channels were
radiolabeled by phosphorylation with 500 ng of cAMP-
dependent protein kinase and 5 ,uCi (1 Ci = 37 GBq) of
[y-32P]ATP for 1 min at 36°C (25).
NaDodSO4 Gel Electrophoresis. Pellets from immunopre-
cipitation and phosphorylation were suspended in 3% Na-
DodSO4/30 mM Tris (adjusted to pH 8.6 with HCI)/2 mM
EDTA/5% sucrose/5% 2-mercaptoethanol and were boiled
for 5 min. The pH was adjusted to 7.4, and the proteins were
resolved by electrophoresis through a stacking gel of 3%
acrylamide and a running gel with a 3-10%o acrylamide
gradient as described (25, 26). Radiolabeled bands were
visualized by autoradiography. The intensity of autoradio-
graphic bands was determined with a soft laser scanning
densitometer (Zeineh SL-504-XL). Exposure times were
selected to give a linear response of the film to the incorpo-
rated radioactivity.
RESULTS AND DISCUSSION
Specific Recognition of RI and RI,. Affinity-purified anti-
bodies were prepared against a peptide (SP1) corresponding
to a conserved sequence in the RI and RI, sodium channel
subtypes and against two peptides (SP111 and SP111I) corre-
sponding to a nearby divergent sequence having only 3
widely spaced amino acids out of 18 that are common
between these subtypes. Immunoprecipitation of purified,
32P-labeled sodium channels by increasing concentrations of
the antibodies directed against the SP1 and SP11 peptides is
illustrated in Fig. 1A. At saturating concentrations, anti-
= 1 00
0
m 80
c 60
A, 40
z 20
cl 0cm
0.01 01 1.0 10.0
Antibody [jiI]
1 00
80
60
40
20
0
- B AntiX1+11
sP I [I
i
FIG. 1. Additive immunoprecipitation of the RI and RI, sodium
channel subtypes. (A) Purified, 32P-labeled sodium channels (50 fmol)
were immunoprecipitated with the indicated volumes of antibodies.
Nonspecific immunoprecipitation (approximately 1% of total) was
measured in the presence of the corresponding peptide (100 JIM) and
was subtracted from the data presented. *, Anti-SP1; *, anti-SP111;
o, anti-SP1111. (B) Additivity of immunoprecipitation of RI and RI,
from a different purified preparation of rat brain sodium channels by
saturating volumes (10 or 20 ,ul as indicated) of anti-SP111 and
anti-SP1111 was measured as in A.
SP11 antibodies precipitated 26% and anti-SP1lII antibodies
precipitated 70% of the 32P-labeled sodium channels in this
preparation that were precipitated by anti-SP1 (Fig. 1A).
Immunoprecipitation by saturating concentrations of anti-
SP11I and anti-SP1lII was additive indicating that these
antibodies immunoprecipitate different populations of puri-
fied sodium channels (Fig. 1B).
The crossreactivity of the anti-SP11I and anti-SP1111 anti-
bodies was examined in the experiment illustrated in Fig. 2.
Immunoprecipitation of 32P-labeled sodium channels by anti-
SP111 is reduced to 50% of maximum by 2.5 nM SP11I or 11.5
nM unlabeled sodium channels, which corresponds to ap-
proximately 2.9 nM RI. Saturating concentrations of unla-
beled sodium channels or SP11 completely block immuno-
precipitation by anti-SP111, but similar concentrations of
SP1111 have no effect. Similarly, immunoprecipitation of
32P-labeled sodium channels by anti-SP1lII is reduced to 50%
of maximum by 0.5 nM SP1111 or 0.8 nM sodium channels,
which corresponds to approximately 0.6 nM R1,. Saturating
concentrations of unlabeled sodium channels or SP11HI com-
pletely block immunoprecipitation by anti-SP1111, but SP11
has no effect. These results show that these anti-peptide
antibodies bind native sodium channels almost as well as the
peptides used as antigens and that they are specific for
distinct a subunit subtypes present in the purified sodium
channel preparation from rat brain. It is likely that they
recognize specifically the RI and RI, sodium channel subtypes
whose primary structures contain the corresponding amino
acid sequences.
Measurement of RI and RI, by Immunoprecipitation and
Phosphorylation. The a subunits of rat brain sodium channels
are unusually good substrates for phosphorylation by cAMP-
dependent protein kinase (17), and both the RI and RI,
subtypes are readily phosphorylated in vitro (Fig. 1). The
phosphorylation sites of these two sodium channel subtypes
are located on the same set of tryptic phosphopeptides,
indicating that RI and RI, are phosphorylated at the same sites
(30). Immunoprecipitating sodium channels with specific
antibodies, radiolabeling the precipitated a subunits by
phosphorylation with cAMP-dependent protein kinase, and
analyzing by NaDodSO4/PAGE provide a sensitive method
for detection of sodium channels in neuronal tissues, which
allows detection of 2 fmol of sodium channels in unpurified
membrane extracts (25). In these experiments, we have
adapted this method to analyze tissue-specific expression of
the RI and RI, sodium channel subtypes using sequence-
specific antibodies.
Sodium channels were solubilized from a lysed crude
synaptosomal membrane fraction (lysed P3; ref. 23) from rat
brain, immunoprecipitated with either anti-SP1, anti-SP111,
or anti-SP1111 antibodies, phosphorylated, and analyzed by
NaDodSO4/PAGE. One major phosphorylated protein band
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FIG. 2. Specificity of immunoprecipitation by anti-SP111 and
anti-SP1111. Fifty femtomoles of 32P-labeled sodium channels were
immunoprecipitated by anti-SP111 (A) or anti-SP111, (B) in the
presence ofthe indicated concentrations of purified sodium channels
(A), SP111 (o), or SP1111 (o).
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of 260 kDa is observed with each antibody (Fig. 3A, lanes
1-3), but it is not observed with preimmune antiserum or
with affinity-purified antibodies that have been previously
blocked by incubation with the corresponding peptide anti-
gen (data not shown). Therefore, this band represents the a
subunits of the sodium channel. Anti-SP1 immunoprecipi-
tates more labeled a subunits than either of the antibodies
directed against variable sequences of the protein (Fig. 3A,
lane 1). In analyzing our results, we have set the amount of
radiolabeled a subunits immunoprecipitated by anti-SP1
antibodies equal to 100% (Fig. 1A) and have compared the
amounts precipitated by anti-SP111 and anti-SP111, to that
value. By this criterion, RI and RI, comprise an average of
15.1% and 60.4%, respectively, of the sodium channels in
membrane preparations from whole rat brain.
Several control experiments were carried out to examine
whether our methods provide an accurate measurement of
the ratio of expression of these two channel subtypes.
Experiments with increased concentrations of antibodies
confirmed that the amounts used were saturating. Measure-
ments of the dissociation rates of the antibody-32P-labeled
sodium channel complex during subsequent centrifugation,
phosphorylation, and washing showed that complexes with
anti-SP1 and anti-SP111 antibodies are recovered quantita-
tively, while approximately 30% of the complexes with anti-
SP11II antibodies are lost. We have applied a correction
factor to account for this in quantitatively analyzing our
results in Table 1 and Fig. 5. With this correction, our results
indicate that the sodium channels in crude synaptosomal
membrane preparations from whole rat brain are 15% RI and
78% RI,. Comparison of these values with those for purified
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nervous system. Membrane fractions containing 100 fmol of saxi-
toxin binding sites were prepared. The RI and RI, sodium channels
were solubilized, immunoprecipitated with anti-SP1 (lanes 1), anti-
SP111 (lanes 2), or anti-SP111, (lanes 3) antibodies, phosphorylated,
and analyzed by NaDodSO4/PAGE and autoradiography. (A) Crude
synaptosomal fraction (lysed P3) from whole rat brain. (B) Cerebral
cortex. (C) Hippocampus. (D) Midbrain. (E) Cerebellum. (F) Me-
dulla oblongata. (G) Spinal cord. (H) Optic nerve.
preparations (Fig. 1A) suggests that the RI subtype is recov-
ered in higher yield during purification.
Variations in the extent of endogenous phosphorylation of
sodium channel subtypes or in dephosphorylation of these
subtypes during tissue fractionation might influence the
extent of radiolabeling of sodium channels in tissue extracts
by phosphorylation. Purified RI and RI, sodium channels are
rapidly dephosphorylated by phosphatases in rat brain cyto-
solic fractions (S. Rossie and W.A.C., unpublished experi-
ments). Prior dephosphorylation of the sodium channels in
extracts of rat brain and spinal cord, which have widely
differing ratios of RI to RI, (see below), by incubation with a
rat brain cytosol fraction before immunoprecipitation and
radiolabeling had no effect on the ratios of RI to RI, observed.
Similarly, prior dephosphorylation of sodium channels from
tissues in which these subtypes were not detected (see below)
did not reveal either subtype. The extent of dephosphoryla-
tion of the cAMP-dependent phosphorylation sites on RI and
RI, during tissue preparation, solubilization, and incubation
with antibodies was measured by the addition of purified,
32P-labeled sodium channels and was found to be compara-
ble. Thus, differential endogenous phosphorylation and dif-
ferential dephosphorylation of sodium channel subtypes
during tissue fractionation do not influence the results de-
scribed below.
RI and RI, Are Expressed Differentially in the Central
Nervous System. Similar analyses ofthe amounts of RI and RI,
were carried out with tissue samples containing 100 fmol of
saxitoxin binding sites from specific regions of the central
nervous system. As illustrated in Fig. 3, hippocampus,
cerebral cortex, and cerebellum expressed substantially less
RI than RI,, with RI/RI, ratios ranging from 0.07 in the
hippocampus to 0.17 in cerebral cortex (Table 1). In these
brain regions, RI and RI, accounted for greater than 90% of
the sodium channels recognized by anti-SP1, the antibody we
have used to define 100% in these studies. If other sodium
channel subtypes are present in these brain regions, they
must either comprise only a small portion of the total, lack
phosphorylation sites, or fail to be recognized by these three
sequence-directed antibodies and our other polyclonal anti-
bodies. In the midbrain, RI, is also expressed at a higher level
than RI (Fig. 3 and Table 1). However, sodium channels that
are recognized by anti-SP1 but not by anti-SP111 or anti-
SP111I are also detected (Table 1). Nevertheless, expression
of the RI, subtype is clearly predominant in these higher brain
Table 1. Differential expression of RI and RI, in the central
nervous system
RI, RI,, Unidentified,
Region % % % RI/R,
Whole brain
Purified Na channels 18 81 <10 0.22
P3 membranes 15 78 <10 0.19
Cerebral cortex 14 79 <10 0.17
Hippocampus 6 97 <10 0.07
Cerebellum 8 84 <10 0.09
Midbrain 9 56 35 0.16
Medulla oblongata 38 39 23 0.98
Spinal cord 39 18 43 2.18
Optic nerve 3 33 64 0.09
Retina 6 18 76 0.36
Autoradiograms similar to those in Fig. 3 were scanned under
conditions where intensity was proportional to input protein, and the
density of the a-subunit bands was quantitated. The intensity of the
a band immunoprecipitated by anti-SP1 antibodies was set at 100%,
and the amounts of RI and RI, were estimated by comparison with
that value using the correction factor described in the text. RI/RI,,
Ratio of RI to RI,.
8684 Neurobiology: Gordon et al.
Proc. Natl. Acad. Sci. USA 84 (1987) 8685
regions among the sodium channel subtypes that are detected
by the methods used here.
In contrast, RI was expressed at comparable or higher
levels than RI, in medulla oblongata and spinal cord, with
RI/RI, ratios of 0.98 and 2.2, respectively (Fig. 3 and Table
1). In addition, in these more caudal regions of the central
nervous system, unidentified sodium channel subtypes that
are recognized by anti-SP1 antibodies but not by anti-SP111
or antj-SP111, antibodies comprised a substantial fraction of
the sodium channels detected. Therefore, expression of both
the RI subtype and unidentified subtypes of sodium channels
in medulla oblongata and spinal cord is increased relative to
the RI, subtype. Since the medulla oblongata contains a
substantial complement of ascending projections from neu-
rons in the spinal cord, much of the RI sodium channel
subtype observed in the medulla could be synthesized by
spinal neurons.
The optic nerve and retina are also considered projections
of the central nervous system. As in the brain, RI, was
expressed preferentially compared to RI in the optic nerve
and retina, with RI/RI, expression ratios of 0.09 and 0.36,
respectively (Fig. 3 and Table 1). However, in contrast to
other regions of the central nervous system, the unidentified
sodium channel subtype(s) was the predominant form ex-
pressed in optic nerve and retina and accounts for 64% and
76% of the sodium channels detected, respectively.
RI and RI, Are Expressed Primarily in the Central Nervous
System. In previous studies, we have shown by radio-
immunoassay that sodium channels in the peripheral nervous
system and skeletal muscle are poorly recognized by poly-
clonal antibodies against rat brain sodium channels (12). To
extend these studies, we first examined if the sodium chan-
nels in several peripheral excitable tissues were recognized
by the anti-SP1 antibodies, which are directed against a
conserved epitope common to RI, RI,, and additional uniden-
tified sodium channels subtype(s) expressed in the central
nervous system. These sodium channel subtypes were not
detected by immunoprecipitation and phosphorylation with
anti-SP! antibodies in samples containing 100 fmol of saxi-
toxin binding sites from skeletal muscle (Fig. 4) or heart (data
not shown), suggesting that RI and RI, are expressed primar-
ily in the nervous system. Similarly, these channel subtypes
were also not detected in sympathetic ganglia or adrenal
medulla (Fig. 4), suggesting that RI and RI, are not expressed
by neurons of the autonomic nervous system or by endocrine
cells. Moreover, neither RI, RI,, nor the additional uniden-
tified sodium channel subtypes recognized by anti-SPI anti-
bodies in the central nervous system were detected in sciatic
nerve, which contains the peripheral projections of spinal
motor neurons, or in cauda equina, the most caudal segment
ofthe spinal cord, which contains fiber tracts within the lower
vertebrae (Fig. 4). These results contrast with expression of
these subtypes in the central myelinated fibers of- the optic
nerve (Fig. 3) and corpus callosum (data not shown). Thus,
previous results (12) and the work presented here suggest that
these channel subtypes are expressed primarily, if not ex-
clusively, by neurons in the central nervous system and are
excluded from the peripheral projections of central neurons.
Since expression ofthe RI and RI, sodium channel subtypes
is restricted to the central nervous system, it was of interest
to examine if the antigenic epitopes that we have used to
define these subtypes are conserved in the central nervous
systems of a range of species. Sodium channels that are
recognized by anti-SP1 antibodies were detected in mamma-
lian (rat and monkey), avian (chicken), reptilian (gecko), and
amphibian (frog) brains but not in a bony fish (electric eel)
brain (Fig. 4B). However, sodium channels that are recog-
nized by anti-SP111 or anti-SP1111 were observed only in
monkey and rat brain. Although only a few species have been
examined, it appears that these epitopes may be conserved
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FIG. 4. Expression of RI and RI, in excitable tissues. (A)
Membrane fractions containing 100 fmol of saxitoxin binding sites
were prepared from rat brain (lane 1), superior cervical ganglia (lane
2), skeletal muscle (lane 3), sciatic nerve (lane 4), and adrenal
medulla (lane 5); sodium channels were solubilized, immunoprecip-
itated with anti-SP1 antibodies, phosphorylated, and analyzed by
NaDodSO4/PAGE and autoradiography. (B) Membrane fractions
were prepared from brains of the indicated species, and sodium
channels were solubilized, immunoprecipitated with anti-SP1 (lanes
1, 4, 7, 10, and 13), anti-SP11, (lanes 2, 5, 8, 11, and 14), or anti-SP1111(lanes 3, 6, 9, 12, and 15), and analyzed by NaDodSO4/PAGE and
autoradiography. Lanes: 1-3, monkey (Macaca nemestrina) brain;
4-6, chicken (Gallus gallus) brain; 7-9, gecko (Gecka gecko) brain;
10-12, frog (Rana pipiens) brain; 13-15, eel (Electrophorus elec-
tricus) brain.
among mammals but are not conserved in most nonmammal-
ian vertebrates.
Expression of RI and RI, Is Differentially Regulated During
Development. Analysis ofthe relative expression of RI and R11
in brain and spinal cord during development reveals addi-
tional levels of regulation (Fig. 5). At birth, the number of
sodium channels in rat or mouse brain per unit wet weight, as
measured by high affinity binding of saxitoxin, is less than
10% of the adult level (27-29). The density of sodium
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FIG. 5. Developmental regulation of the expression of RI and RI,.
(A) Brains were rapidly dissected from rats of the indicated ages, the
cerebella were removed, and membrane fractions were isolated.
Specific saxitoxin binding (A) was measured at a saturating concen-
tration (20 nM). Sodium channels were solubilized, immunoprecip-
itated with anti-SP1111 (r) or anti-SP111 (X) antibodies, phosphoryl-
ated, and analyzed by NaDodSO4/PAGE and autoradiography. The
percentages of RI and RI, were multiplied by the total number of
saxitoxin binding sites to give pmol of RI and RI, per mg of protein.
(B) A similar experiment was carried out with rat spinal cord, and the
data for both brain and spinal cord were plotted as the ratio of RI/RI,.
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channels per unit wet weight in brains with the cerebella
removed increases steadily during the first 28 days after birth,
reaching 1.8 times the adult level, and declines thereafter
returning to the adult level by 90 days. The time course of
development of total sodium channels is paralleled by the
time course of appearance of sodium channels of the RI,
subtype (Fig. 5). RI, is present at approximately 7% of the
adult level at birth, increases to 1.8 times the adult level by
days 21-28, and declines toward the adult value by day 90. In
contrast, RI is not clearly detectable until 14 days after birth
and increases to the adult level by 28 days (Fig. 5A). The ratio
of RI to RI, rises steadily over the entire time course of
development that we have examined, increasing from 0 on
day 7 to 0.19 on day 90 (Fig. SB).
We also examined the expression of RI and RI, in newborn
and adult spinal cord (Fig. SB). As in brain, RI1 was prefer-
entially expressed in the newborn spinal cord, and expression
of RI increased progressively during development in the
adult. In contrast to brain, expression of RI, was reduced in
adult, and RI was the predominant subtype expressed.
Tissue-Specific Expression of Sodium Channel Subtypes.
Three or more different sodium channel subtypes are ex-
pressed in the rat central nervous system: RI, RI,, and at least
one unidentified subtype that is recognized by anti-SP1
antibodies but not by anti-SP11I or anti-SP1111 antibodies.
The unidentified subtype that we have detected in the central
nervous system in our immunoprecipitation experiments may
be encoded by the third sodium channel mRNA that Noda et
al. (8) detected in rat brain cDNA libraries but did not
sequence fully. RI is preferentially expressed in the spinal
cord, RI, is preferentially expressed in the brain, and the
unidentified subtype(s) recognized by anti-SP, antibodies is
preferentially expressed in retina and optic nerve and to a
lesser extent in the spinal cord. In addition to these three or
more sodium channel subtypes in the central nervous system,
our results provide clear evidence that the sodium channels
that are expressed in the peripheral nervous system represent
one or more distinct subtypes. Polyclonal antibodies against
rat brain sodium channels and anti-peptide antibodies direct-
ed against the SP1, SP111, and SP1111 segments of the a
subunit all recognize sodium channels in the central nervous
system but not those in the peripheral nervous system (ref. 12
and this paper). Sodium- channel subtypes other than RI and
RI, must also be expressed in skeletal and cardiac muscle
because our experiments with specific antibodies do not
detect RI or RI, in muscle tissues (ref. 12 and Fig. 4).
Correlation of differences in pharmacological and physiolog-
ical properties with differences in the primary structure of
these six or more sodium channel subtypes is an important
area for future work.
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